Author: Mark Newman

Share

Endocrine Society Honors Endocrinology Leaders with 2026 Laureate Awards 

The Endocrine Society today announced it has chosen 12 leading endocrinologists as winners of its prestigious 2026 Laureate Awards, the top honors in the field. These professionals have achieved breakthroughs in scientific discoveries and clinical care benefiting people with hundreds of conditions, including diabetes, thyroid disorders, obesity, hormone-related cancers, growth problems, osteoporosis and infertility. Established...
Share

Pharma Fridays – September 5, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves MiniMed 780g System for Adults with Type 2 Diabetes On September 2, Medtronic announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated...
Share

Endocrine Society Grows Program to Boost Endocrinology Interest in Medical School Students and Offers Obesity Fellows Program This Fall

Lange ENDO 2 As summertime draws to a close in the Northern Hemisphere, medical schools once again are buzzing with activity: students rushing between classes, attending labs, making grand rounds, and hitting the books late into the night. For a growing number of these students, endocrinology will be part of the mix. Eleven U.S. universities have joined 10...
Share

Post-ENDO 2025 Afterglow: Saluting Early-Career Members

I’ll admit it: After ENDO each year I get into what I call the “post-ENDO funk” because, well, I enjoyed ENDO so much. It’s kind of like the post-holiday lows many people feel after Christmas, Thanksgiving, and New Year’s, but more ENDO focused! And ENDO 2025 in San Francisco last month was certainly no exception....
Share

Advocacy in Action – September 2025

September Will Be Critical Legislative Month in Congress; Endocrine Society Advocates for Policy Priorities   When the Congress returned to Washington, D.C., September 2 from its six-week recess, it will have only 28 days to pass legislation to fund the federal government or face a government shutdown. The federal fiscal year ends September 30, and by...
Share

Star Power 2025: Chatting with This Year’s Rising Star Power Talks Winners

Each year at ENDO, early-career and in-training members get their chances to shine bright at the Rising Star Power Talks. Endocrine News caught up with this year’s winners during ENDO 2025 in San Francisco last month to learn more about their research, future plans, and more. During last month’s ENDO 2025 in San Francisco, Room...
Share

Pharma Fridays – August 22, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves Wegovy (semaglutide) to Treat MASH On August 15, the U.S. Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (excessive scar tissue in the liver). MASH, also known as nonalcoholic steatohepatitis,...
Share

Putting Your Research Paper in the Spotlight

Seasoned researchers and scientists are all too familiar with the adage “publish or perish.” However, as science and technology have evolved together, so too has the process. In other words, getting your paper in that prestigious peer-reviewed journal is just the first step in presenting your work to a broader audience. You and your colleagues...